In patients with prostate cancer, germline pathogenic BRCA1/2 variants are usually correlated with poor prognostic characteristics (aggressiveness, castration resistance, lymph node invasion and metastasis at diagnosis, and decreased overall survival) [13,14,15,16,17]. Here, BRCA1 is linked to prostate carcinoma.